OurCrowd is a Jerusalem-based global investing platform that enables institutions and accredited individuals to co-invest in venture-backed startups. It is not a traditional single-fund VC in the same way as many other firms, but it has become a significant participant in global venture rounds. Its model combines platform-based capital aggregation with venture access and curation.

The platform has backed neurotech companies such as BRAIN.Q and Firefly Neuroscience, showing appetite for clinically grounded neurotechnology and regulated healthtech. OurCrowd can be useful not just as a capital source, but as a network amplifier, particularly for companies with international or Israel-linked visibility. Its structure often makes it a useful co-investor in competitive rounds.

OurCrowd invests globally, with a strong Israel emphasis and international reach across multiple markets. For neurotech, it is especially relevant to founders seeking broad investor exposure, strong Israeli ecosystem ties, and participation from a platform with demonstrated appetite for regulated brain-health innovation. It is more of a syndication and access engine than a pure thesis-led neuro specialist.